Subscribe to RSS
DOI: 10.1055/a-2779-7133
Neurodevelopmental Outcome after Late-Onset Bacterial Sepsis in Infants Born before 29 Weeks' Gestation
Authors
Funding Information No specific funding has been received for this study. However, organizational support for the Canadian Neonatal Network was provided by the Maternal-Infant Care Research Centre (MiCare) at Mount Sinai Hospital in Toronto, Ontario, Canada.
Abstract
Objective
Neonatal late-onset sepsis is associated with increased mortality and morbidity, adversely impacting long-term outcome. The objective of this study was to examine neurodevelopmental (ND) outcomes at 18 to 24 months' corrected age (CA) in infants with late-onset bacterial sepsis (LOS) and to categorize outcomes based on type of bacterial pathogen in a cohort of preterm infants born less than 29 weeks gestation in Canada.
Study Design
We conducted a retrospective cohort study of all non-anomalous infants born at <29 weeks gestational age (GA) who were admitted to Canadian NICUs, from January 1, 2010, to December 31, 2017, who had an ND assessment at 18 to 24 months' CA at Canadian Neonatal Follow-Up Network clinics. The primary outcome was the composite outcome of death or ND impairment (NDI). Secondary outcomes included significant NDI, and each component of primary outcome. We compared ND outcomes among infants with Gram-positive (GP) sepsis, Gram-negative (GN) sepsis, mixed sepsis, and no sepsis using bivariate and multivariate analyses after adjusting for potential confounders.
Results
Of the 3,640 infants included, 823 (22.6%) developed LOS. Of the 823 infants, 569 (69.1%) had GP sepsis, 172 (20.9%) had GN sepsis, and 82 (10%) had mixed sepsis. Infants with LOS had significantly lower birth weight, GA, younger mothers, and significantly higher rates of major neonatal morbidities compared with the no-sepsis group. In multivariable logistic regression, infants with GN sepsis and mixed sepsis had significantly higher odds of death/NDI (GN sepsis, adjusted odds ratio [aOR] = 1.80; 95% CI: 1.27, 2.54; mixed LOS, aOR = 2.38, 95% CI: 1.41, 4.01) as compared with no sepsis.
Conclusion
Late-onset bacterial sepsis, particularly Gram-negative and mixed sepsis, was associated with an increased risk of adverse outcomes including death or NDI at 18 to 24 months CA in infants born <29 weeks' GA in Canada.
Key Points
-
Late-onset sepsis is an important risk factor for morbidity and mortality in preterm infants.
-
The clinical presentations vary depending on the causative bacteria.
-
There is limited data on neurodevelopmental outcomes based on type of bacterial pathogen.
Keywords
bacteria - cognitive score - death - late-onset sepsis - neurodevelopmental outcome - pathogen‡ Network details are available in the [Supplementary Material] (available in the online version only).
Publication History
Received: 01 April 2025
Accepted: 22 December 2025
Article published online:
29 January 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Shah PS, McDonald SD, Barrett J. et al; Canadian Preterm Birth Network Investigators. The Canadian Preterm Birth Network: a study protocol for improving outcomes for preterm infants and their families. CMAJ Open 2018; 6 (01) E44-E49
- 2 Stoll BJ, Hansen NI, Bell EF. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 2015; 314 (10) 1039-1051
- 3 Younge N, Goldstein RF, Bann CM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Survival and neurodevelopmental outcomes among periviable infants. N Engl J Med 2017; 376 (07) 617-628
- 4 Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012; 379 (9814) 445-452
- 5 Synnes A, Luu TM, Moddemann D. et al; Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network. Determinants of developmental outcomes in a very preterm Canadian cohort. Arch Dis Child Fetal Neonatal Ed 2017; 102 (03) F235-F234
- 6 Stoll BJ, Hansen NI, Adams-Chapman I. et al; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292 (19) 2357-2365
- 7 Flannery DD, Edwards EM, Coggins SA, Horbar JD, Puopolo KM. Late-onset sepsis among very preterm infants. Pediatrics 2022; 150 (06) e2022058813
- 8 Klinger G, Reichman B, Norman M. et al; International Network for Evaluating Outcomes of Neonates (iNeo). Late-onset sepsis among extremely preterm infants of 24–28 weeks gestation: an international comparison in 10 high-income countries. Neonatology 2024; 121 (06) 761-771
- 9 Huncikova Z, Vatne A, Stensvold HJ. et al; Norwegian Neonatal Network. Late-onset sepsis in very preterm infants in Norway in 2009-2018: a population-based study. Arch Dis Child Fetal Neonatal Ed 2023; 108 (05) 478-484
- 10 Lee J, Lee CYM, Naiduvaje K. et al. Trends in neonatal mortality and morbidity in very-low-birth-weight (VLBW) infants over a decade: Singapore national cohort study. Pediatr Neonatol 2023; 64 (05) 585-595
- 11 Hornik CP, Fort P, Clark RH. et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88 (Suppl. 02) S69-S74
- 12 Köstlin-Gille N, Härtel C, Haug C. et al. Epidemiology of early and late onset neonatal sepsis in very low birthweight infants: data from the German Neonatal Network. Pediatr Infect Dis J 2021; 40 (03) 255-259
- 13 Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002; 109 (01) 34-39
- 14 Dong Y, Glaser K, Speer CP. Late-onset sepsis caused by Gram-negative bacteria in very low birth weight infants: a systematic review. Expert Rev Anti Infect Ther 2019; 17 (03) 177-188
- 15 Tsai M-H, Hsu J-F, Chu S-M. et al. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 2014; 33 (01) e7-e13
- 16 Shah J, Jefferies AL, Yoon EW, Lee SK, Shah PS. Canadian Neonatal Network. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at < 32 weeks' gestation. Am J Perinatol 2015; 32 (07) 675-682
- 17 Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol 2013; 33 (07) 558-564
- 18 Cai S, Thompson DK, Anderson PJ, Yang JY. Short- and long-term neurodevelopmental outcomes of very preterm infants with neonatal sepsis: a systematic review and meta-analysis. Children (Basel) 2019; 6 (12) 131
- 19 van der Ree M, Tanis JC, Van Braeckel KN, Bos AF, Roze E. Functional impairments at school age of preterm born children with late-onset sepsis. Early Hum Dev 2011; 87 (12) 821-826
- 20 de Haan TR, Beckers L, de Jonge RC. et al. Neonatal gram negative and Candida sepsis survival and neurodevelopmental outcome at the corrected age of 24 months. PLoS One 2013; 8 (03) e59214
- 21 Hentges CR, Silveira RC, Procianoy RS. et al. Association of late-onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight. J Pediatr (Rio J) 2014; 90 (01) 50-57
- 22 Rand KM, Austin NC, Inder TE, Bora S, Woodward LJ. Neonatal infection and later neurodevelopmental risk in the very preterm infant. J Pediatr 2016; 170: 97-104
- 23 Bright HR, Babata K, Allred EN. et al; ELGAN Study Investigators. Neurocognitive outcomes at 10 years of age in extremely preterm newborns with late-onset bacteremia. J Pediatr 2017; 187: 43-49.e1
- 24 Mukhopadhyay S, Puopolo KM, Hansen NI. et al; NICHD Neonatal Research Network. Neurodevelopmental outcomes following neonatal late-onset sepsis and blood culture-negative conditions. Arch Dis Child Fetal Neonatal Ed 2021; 106 (05) 467-473
- 25 Shim SY, Cho SJ, Park EA. Neurodevelopmental outcomes at 18–24 months of corrected age in very low birth weight infants with late-onset sepsis. J Korean Med Sci 2021; 36 (35) e205
- 26 Zonnenberg IA, van Dijk-Lokkart EM, van den Dungen FAM, Vermeulen RJ, van Weissenbruch MM. Neurodevelopmental outcome at 2 years of age in preterm infants with late-onset sepsis. Eur J Pediatr 2019; 178 (05) 673-680
- 27 Dos Santos Engel J, Mota de Almeida MA, Costa R, Freitas AI. Late-onset neonatal sepsis was not associated with impaired neurodevelopmental outcome: results from the EPICE/SHIPS-PT cohort. Acta Paediatr 2024; 113 (06) 1306-1314
- 28 Canadian Neonatal Network. Abstractor manual v3.5.0. 2021. Canadian Neonatal Network; 2021. . Accessed at: http://www.canadianneonatalnetwork.org/portal/Portals/0/CNN%20Manuals/CNN%20Manual_20210225.pdf
- 29 Zhou Q, Ong M, Lan M. et al; Canadian Neonatal Network (CNN) Investigators. Decreasing trend in incidence of late onset culture positive bloodstream infections but not late onset meningitis in preterm infants <33 weeks gestation in Canadian Neonatal Intensive Care Unit. Neonatology 2022; 119 (01) 60-67
- 30 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
- 31 Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82 (04) 527-532
- 32 Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33 (01) 179-201
- 33 Rosenbaum P, Paneth N, Leviton A. et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol suppl 2007; 109: 8-14
- 34 Bayley N. Bayley Scales of Infant and Toddler Development, Third Edition: Administration Manual. San Antonio, TX: Harcourt; 2006
- 35 Glass HC, Bonifacio SL, Chau V. et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 2008; 122 (02) 299-305
- 36 Humberg A, Fortmann MI, Spiegler J. et al; German Neonatal Network (GNN). Recurrent late-onset sepsis in extremely low birth weight infants is associated with motor deficits in early school age. Neonatology 2022; 119 (06) 695-702
- 37 Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K. New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014; 133 (01) 55-62
- 38 Polin RA, Harris MC. Neonatal bacterial meningitis. Semin Neonatol 2001; 6 (02) 157-172
- 39 Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006; 19 (03) 290-297
- 40 Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50 (05) 553-562
- 41 Back SA, Han BH, Luo NL. et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22 (02) 455-463
- 42 Plata-Salamán CR, Ilyin SE, Gayle D, Flynn MC. Gram-negative and gram-positive bacterial products induce differential cytokine profiles in the brain: analysis using an integrative molecular-behavioral in vivo model. Int J Mol Med 1998; 1 (02) 387-397
- 43 Kurul Ş, Beckers FLM, Vermeulen MJ. et al. Inflammation, sepsis severity and neurodevelopmental outcomes of late-onset sepsis in preterm neonates. Pediatr Res 2023; 94 (06) 2026-2032
- 44 Liu C, Zhu X, Li D, Shi Y. Related factors of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Front Pediatr 2021; 8: 605879
- 45 Schmidt B, Anderson PJ, Doyle LW. et al; Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307 (03) 275-282
